KEVIN CREEDON: Open Payments
NPI 1063951952 · PERRYSBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$419 in 16 payments from 9 companies in 2025. Trend: 2023 $460 · 2024 $426 · 2025 $419
Food & beverage: $419
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $142 |
| Novo Nordisk Inc | 3 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| SCPHARMACEUTICALS INC. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $18 |
Products named: BRILINTA, Wegovy, LEQVIO, FUROSCIX, Kerendia, JARDIANCE, Attruby, ELIQUIS.
Industry payments across OH — which companies pay providers there.
